Controlling Covid-19 Needs More Than Just A Vaccine; It Requires An Integrated Control Strategy

E. Abdallah
{"title":"Controlling Covid-19 Needs More Than Just A Vaccine; It Requires An Integrated Control Strategy","authors":"E. Abdallah","doi":"10.38125/oajbs.000365","DOIUrl":null,"url":null,"abstract":"The ongoing worldwide pandemic of Coronavirus Disease 2019 (COVID-19), which outbroke in December 2019 in China (Wuhan) and quickly spread around the world, is the most widespread and devastating infection in the present time [1]. This virus produces a severe lower respiratory tract infection, with viral pneumonia occurring in roughly 75% of COVID-19 hospitalized patients. Despite the fact that the mortality rate associated with COVID-19 is only 2%, much less than the earlier zoonotic coronavirus epidemics such as 10 % for Severe acute respiratory syndrome (SARS) and 30% for Middle East Respiratory Syndrome (MERS) [2], and. 50% for Ebola. Accordingly, COVID-19 is not the deadliest viral disease. However, COVID-19 is more contagious than SARS and MERS and its high spread rate is fraught with hazards, requiring stringent policies and plans [3]. Interestingly, the wide range of animal species vulnerable to COVID-19 clearly implies that these viruses have the potential to overcome the species barriers, especially given the frequent interactions between predators and other small mammals that might aid interspecies transmission [4]. The scientific community has put forth a lot of efforts to combat this pandemic, and as a result, a range of vaccines have been developed. COVID-19 variants are constantly emerging, which is unfortunate. Without intervention, vaccination against COVID-19 alone could lead to continued dissemination and the generation of new variants [5], necessitating the continuous use of booster doses. In addition to continuing to develop more effective vaccinations, new integrated strategies must be established. Accordingly, the suggested integrative strategy should include:","PeriodicalId":207626,"journal":{"name":"Open Access Journal of Biomedical Science","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Access Journal of Biomedical Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.38125/oajbs.000365","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

The ongoing worldwide pandemic of Coronavirus Disease 2019 (COVID-19), which outbroke in December 2019 in China (Wuhan) and quickly spread around the world, is the most widespread and devastating infection in the present time [1]. This virus produces a severe lower respiratory tract infection, with viral pneumonia occurring in roughly 75% of COVID-19 hospitalized patients. Despite the fact that the mortality rate associated with COVID-19 is only 2%, much less than the earlier zoonotic coronavirus epidemics such as 10 % for Severe acute respiratory syndrome (SARS) and 30% for Middle East Respiratory Syndrome (MERS) [2], and. 50% for Ebola. Accordingly, COVID-19 is not the deadliest viral disease. However, COVID-19 is more contagious than SARS and MERS and its high spread rate is fraught with hazards, requiring stringent policies and plans [3]. Interestingly, the wide range of animal species vulnerable to COVID-19 clearly implies that these viruses have the potential to overcome the species barriers, especially given the frequent interactions between predators and other small mammals that might aid interspecies transmission [4]. The scientific community has put forth a lot of efforts to combat this pandemic, and as a result, a range of vaccines have been developed. COVID-19 variants are constantly emerging, which is unfortunate. Without intervention, vaccination against COVID-19 alone could lead to continued dissemination and the generation of new variants [5], necessitating the continuous use of booster doses. In addition to continuing to develop more effective vaccinations, new integrated strategies must be established. Accordingly, the suggested integrative strategy should include:
控制Covid-19需要的不仅仅是疫苗;它需要一个综合的控制策略
2019年12月在中国(武汉)爆发并迅速蔓延到世界各地的2019冠状病毒病(COVID-19)正在全球大流行,是当今世界范围内最广泛和最具破坏性的感染。这种病毒会导致严重的下呼吸道感染,大约75%的COVID-19住院患者发生病毒性肺炎。尽管与COVID-19相关的死亡率仅为2%,远低于早期人畜共患的冠状病毒流行病,如严重急性呼吸综合征(SARS)的10%和中东呼吸综合征(MERS)的30%。50%是埃博拉病毒。因此,COVID-19不是最致命的病毒性疾病。然而,新冠肺炎的传染性比SARS和MERS更强,其高传播率充满了危险,需要严格的政策和计划。有趣的是,对COVID-19易感的动物物种范围很广,这清楚地表明,这些病毒有可能克服物种障碍,特别是考虑到捕食者和其他小型哺乳动物之间频繁的相互作用,这可能有助于物种间传播[4]。科学界为抗击这一流行病作出了大量努力,因此开发出了一系列疫苗。不幸的是,新冠病毒的变种不断出现。如果不采取干预措施,单独接种COVID-19疫苗可能导致持续传播和产生新的变体[5],从而需要持续使用加强剂量。除了继续发展更有效的疫苗接种外,还必须制定新的综合战略。因此,建议的综合战略应包括:
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信